Aflibercept 2 mg biosimilars—will they lead the Anti-VEGF biosimilar world globally
Academic Article
Publication Date:
2025
Short description:
Aflibercept 2 mg biosimilars—will they lead the Anti-VEGF biosimilar world globally / Sharma, A., Woo, S.J., Lee, C.S., Kumar, N., Parachuri, N., Bandello, F., Loewenstein, A., Kuppermann, B.D.. - In: EYE. - ISSN 0950-222X. - 39:6(2025), pp. 1026-1027. [10.1038/s41433-025-03732-2]
Iris type:
1.1 Articolo in rivista
List of contributors:
Sharma, A.; Woo, S. J.; Lee, C. S.; Kumar, N.; Parachuri, N.; Bandello, F.; Loewenstein, A.; Kuppermann, B. D.
Published in: